KC-1933-DW

MC38-LRRC15 Cell Line

×
Please enable JavaScript in your browser to complete this form.
59218
Home » 细胞系 » MC38-LRRC15 Cell Line

Background of MC38-LRRC15 Cell Line

LRRC15 (Leucine Rich Repeat Containing 15) is a transmembrane protein that enables several functions, including collagen binding activity, integrin binding activity, and TGF-β sequestration. It is involved in several biological processes, such as negative regulation of TGF-β signaling pathway, modulation of immune cell infiltration, and tissue fibrosis. Located primarily in the plasma membrane, LRRC15 is highly active at the cell surface where it interacts with extracellular matrix components. Its specific expression on cancer-associated fibroblasts (CAFs) in multiple solid tumors positions LRRC15 as a key regulator of the tumor microenvironment and an emerging therapeutic target for modulating stromal biology in oncology.

Specifications

Catalog NumberKC-1933-DW
Cell Line NameMC38-LRRC15 Cell Line
Clone Number4#
Host Cell LineMC38
DescriptionStable MC38 cell line expressing exogenous LRRC15 gene
QuantityTwo vials of frozen cells (≥2-106/vial)
StabilityStable in culture over a minimum of 10 passages
ApplicationDrug screening and biological assays
Freezing Medium70% DMEM+20% FBS+10% DMSO
Propagation MediumDMEM+10% FBS +5μg/mL Puromycin
Selection MarkerPuromycin
MorphologyEpithelial
SubcultureSplit saturated culture 1:4-1:8 every 2-3 days; seed out at about 1-3 × 105 cells/mL
Incubation37 °C with 5% CO2
StorageLiquid nitrogen immediately upon receiving
Doubling TimeApproximately 30 hours
Mycoplasma StatusNegative

Cell Line Generation

MC38-LRRC15 cell line was generated using lentivirus expressing LRRC15 sequence.

Characterization

Figure 1. Characterization of LRRC15 over-expression in the MC38-LRRC15 stable clone using FACS.[Primary antibody: PR1498487-G1-LRRC15, Cat#KA-1254, Kyinno]

Figure 2:Validation of in vivo tumorigenicity of MC38 cells stably expressing LRRC15 via subcutaneous implantation in C57BL/6 mice, with tumor growth monitored by measuring volume (V=0.5×length×width²) and body weight.

Cell Resuscitation

  1. Prewarm culture medium (DMEM supplemented with 10% FBS, 5μg/mL Puromycin)in a 37°C water bath.
  2. Thaw the frozen vial in a 37°C water bath for 1-2 minutes.
  3. Transfer the vial into biosafety cabinet, and wipe the surface with 70% ethanol.
  4. Unscrew the top of the vial and transfer the cell suspension gently into a sterile centrifuge tube containing 9.0mL complete culture medium.
  5. Spin at ~ 125 × g for 5-7 minutes at room temperature, and discard the supernatant without disturbing the pellet.
  6. Resuspend cell pellet with the appropriate volume of complete medium and transfer the cell suspension into a T25 culture flask.
  7. Incubate the flask at 37°C, 5% CO2 incubator.
  8. Split saturated culture 1:4-1:8 every 2-3 days; seed out at about 1-3 × 105 cells/mL.

Cell Freezing

  1. Prepare the freezing medium (70% DMEM + 20% FBS + 10% DMSO) fresh immediately before use.
  2. Keep the freezing medium on ice and label cryovials.
  3. Transfer cells to a sterile, conical centrifuge tube, and count the cells.
  4. Centrifuge the cells at 250×g for 5 minutes at room temperature and carefully aspirate off the medium.
  5. Resuspend the cells at a density of at least 3×106 cells/mL in chilled freezing medium.
  6. Aliquot 1 mL of the cell suspension into each cryovial.
  7. Freeze cells in the CoolCell freezing container overnight in a -80°C freezer.
  8. Transfer vials to liquid nitrogen for long-term storage.

References

  1. Tang H, Liu W, Xu Z, Zhao J, Wang W, Yu Z, Wei M. Integrated microenvironment-associated genomic profiles identify LRRC15 mediating recurrent glioblastoma-associated macrophages infiltration. J Cell Mol Med. 2021 Jun;25(12):5534-5546. doi: 10.1111/jcmm.16563. Epub 2021 May 7. PMID: 33960636; PMCID: PMC8184692.
  2. Purcell JW, Tanlimco SG, Hickson J, Fox M, Sho M, Durkin L, Uziel T, Powers R, Foster K, McGonigal T, Kumar S, Samayoa J, Zhang D, Palma JP, Mishra S, Hollenbaugh D, Gish K, Morgan-Lappe SE, Hsi ED, Chao DT. LRRC15 Is a Novel Mesenchymal Protein and Stromal Target for Antibody-Drug Conjugates. Cancer Res. 2018 Jul 15;78(14):4059-4072. doi: 10.1158/0008-5472.CAN-18-0327. Epub 2018 May 15. PMID: 29764866.
Please enable JavaScript in your browser to complete this form.